MoneyWorks4Me

Lupin informs about board meeting

23 Jan 2019 Evaluate

Pursuant to Regulation 29(1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that a meeting of the Board of Directors of the company will be held on Wednesday, February 6, 2019, at Mumbai, to consider and take on record unaudited financial results for the quarter ended December 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..